Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-054094

Director sold 50,489 shares at an average $29.24 ($1,476,135)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GADICKE ANSBERT Director 2021-08-27 Sale −1,846 $29.09 $53,700 264,437 D
GADICKE ANSBERT Director 2021-08-27 Sale −13,357 $29.09 $388,555 7,792,126 I
GADICKE ANSBERT Director 2021-08-30 Sale −4,285 $29.30 $125,551 260,152 D
GADICKE ANSBERT Director 2021-08-30 Sale −31,001 $29.30 $908,329 7,761,125 I
Open-market sales · 50,489 sh · avg $29.24 · $1,476,135
Loading xslF345X03/doc4.xml…